Cargando…
Myasthenia gravis
Myasthenia gravis (MG) is a rare, autoimmune neuromuscular junction disorder. Contemporary prevalence rates approach 1/5,000. MG presents with painless, fluctuating, fatigable weakness involving specific muscle groups. Ocular weakness with asymmetric ptosis and binocular diplopia is the most typical...
Autores principales: | Juel, Vern C, Massey, Janice M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211463/ https://www.ncbi.nlm.nih.gov/pubmed/17986328 http://dx.doi.org/10.1186/1750-1172-2-44 |
Ejemplares similares
-
Characterization of B cells in muscle-specific kinase antibody myasthenia gravis
por: Guptill, Jeffrey T., et al.
Publicado: (2015) -
B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease Severity
por: Yi, John S., et al.
Publicado: (2017) -
Clinicoserological insights into patients with immune checkpoint inhibitor‐induced myasthenia gravis
por: Masi, Gianvito, et al.
Publicado: (2023) -
The epidemiology of myasthenia gravis
por: Bubuioc, Ana-Maria, et al.
Publicado: (2021) -
Diagnosis of Myasthenia Gravis
por: Rousseff, Rossen T.
Publicado: (2021)